Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Gains from Investment Securities (2018 - 2021)

Entera Bio has reported Gains from Investment Securities over the past 4 years, most recently at -$29000.0 for Q3 2021.

  • For the quarter ending Q3 2021, Gains from Investment Securities changed N/A year-over-year to -$29000.0, compared with a TTM value of -$29000.0 through Dec 2022, down 1550.0%, and an annual FY2022 reading of $165000.0, up 8150.0% over the prior year.
  • Gains from Investment Securities came in at -$29000.0 for Q3 2021, down from $31000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $66000.0 in Q4 2020 to a low of -$29000.0 in Q3 2021.
  • Median Gains from Investment Securities over the past 4 years was $27000.0 (2018), compared with a mean of $24500.0.
  • The sharpest move saw Gains from Investment Securities skyrocketed 43.48% in 2019, then surged 34.78% in 2021.
  • Over 4 years, Gains from Investment Securities stood at $23000.0 in 2018, then soared by 43.48% to $33000.0 in 2019, then surged by 100.0% to $66000.0 in 2020, then crashed by 143.94% to -$29000.0 in 2021.
  • Per Business Quant, the three most recent readings for ENTX's Gains from Investment Securities are -$29000.0 (Q3 2021), $31000.0 (Q1 2021), and $66000.0 (Q4 2020).